PTC Therapeutics GAAP EPS of $0.20, revenue of $211M beats by $35.48M

2 hours ago 1

PTC Therapeutics press release (PTCT): Q3 GAAP EPS of $0.20.
Revenue of $211M (+7.2% Y/Y) beats by $35.48M.
Total revenue includes net product revenue across the commercial portfolio of $131.0 million for the third quarter of 2025, compared to $135.4 million for the